Scientech Research LLC’s CVS Health CVS Stock Holding History

Scientech Research LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,327	Closed	-$209K	–	636
2024 Q3	$209K	Buy	+3,327	New	+$194K	0.04%	547

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Scientech Research LLC's CVS Position: Q4 2024 in Review

Scientech Research LLC sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,327 shares — an estimated $209K sold.

Scientech Research LLC first reported a position in CVS in Q3 2024 and held it in 1 quarter. The position peaked at $209K in Q3 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Scientech Research LLC reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Scientech Research LLC sold 3,327 CVS Health shares in Q4 2024, an estimated $209K.
Scientech Research LLC first reported a position in CVS Health in Q3 2024 and held it in 1 quarter.
Scientech Research LLC's CVS Health position peaked at $209K in Q3 2024.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Scientech Research LLC's 13F filing for Q4 2024, filed 14 Feb 2025.